Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction
- PMID: 21444843
- DOI: 10.1001/archinternmed.2011.57
Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction
Abstract
Background: Current ST-segment elevation myocardial infarction guidelines regarding reperfusion strategy are based on trials conducted before the application of routine invasive evaluation after thrombolysis. Modern thrombolysis may affect the previously observed mortality difference between primary percutaneous coronary intervention (PPCI) and thrombolysis.
Methods: In-hospital mortality was prospectively assessed in 5295 patients with ST-segment elevation myocardial infarction admitted to 73 Belgian hospitals from July 1, 2007, through December 31, 2009. A total of 4574 patients (86.4%) were treated with PPCI and 721 (13.6%) received thrombolysis; of these thrombolysis patients, 603 (83.6%) underwent subsequent invasive evaluation. The Thrombolysis in Myocardial Infarction risk score was used to stratify the study population by low (n = 1934), intermediate (n = 2382), and high (n = 979) risk.
Results: In-hospital mortality in the PPCI patients was 5.9% vs 6.6% in the thrombolysis patients. After adjustment for differences in baseline risk profile, a significant mortality benefit was only present in the high-risk groups: 23.7% in the PPCI patients vs 30.6% in the thrombolysis patients. For patients not at high risk, the mortality difference was marginal. For low-risk patients, mortality was 0.3% in the PPCI patients vs 0.4% in the thrombolysis patients. For intermediate-risk patients, mortality was 2.9% in the PPCI patients vs 3.1% in the thrombolysis patients. Subgroup analysis revealed that the mortality benefit of PPCI compared with early thrombolysis (door-to-needle time <30 minutes) was offset if the door-to-balloon time exceeded 60 minutes.
Conclusions: Modern thrombolytic strategies have substantially attenuated the absolute mortality benefit of PPCI over thrombolysis, particularly in patients not at high risk. Our study findings suggest that target door-to-balloon time should be less than 60 minutes to maintain the lowest mortality rates.
Similar articles
-
Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).Circulation. 2008 Jul 15;118(3):268-76. doi: 10.1161/CIRCULATIONAHA.107.762765. Epub 2008 Jun 30. Circulation. 2008. PMID: 18591434
-
Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.Kardiol Pol. 2006 Jun;64(6):591-9; discussion 600-1. Kardiol Pol. 2006. PMID: 16810577
-
Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005. Epub 2010 Apr 14. Am J Cardiol. 2010. PMID: 20494656 Clinical Trial.
-
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.Eur Heart J. 2010 Sep;31(17):2156-69. doi: 10.1093/eurheartj/ehq204. Epub 2010 Jul 2. Eur Heart J. 2010. PMID: 20601393 Review.
-
Effectiveness and safety of percutaneous coronary intervention after fibrinolytic therapy for ST-segment elevation acute myocardial infarction.Am J Cardiol. 2011 Apr 1;107(7):1001-9. doi: 10.1016/j.amjcard.2010.11.024. Epub 2011 Jan 20. Am J Cardiol. 2011. PMID: 21256466 Review.
Cited by
-
Organisation of reperfusion therapy for STEMI in a developing country.Open Heart. 2015 May 21;2(1):e000240. doi: 10.1136/openhrt-2015-000240. eCollection 2015. Open Heart. 2015. PMID: 26019883 Free PMC article.
-
Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry.Clin Res Cardiol. 2013 Nov;102(11):837-45. doi: 10.1007/s00392-013-0600-3. Epub 2013 Jul 26. Clin Res Cardiol. 2013. PMID: 23887831
-
Severe hypocalcemia and hypercalciuria due to contrast medium in the course of acute myocardial infarction.Anatol J Cardiol. 2016 Jul;16(7):543-5. doi: 10.14744/AnatolJCardiol.2016.7130. Anatol J Cardiol. 2016. PMID: 27389156 Free PMC article. No abstract available.
-
Clinical Characteristics and Outcomes of Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study.Glob Heart. 2024 Dec 30;19(1):99. doi: 10.5334/gh.1383. eCollection 2024. Glob Heart. 2024. PMID: 39758148 Free PMC article.
-
Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry.J Am Heart Assoc. 2016 Oct 6;5(10):e004113. doi: 10.1161/JAHA.116.004113. J Am Heart Assoc. 2016. PMID: 27792640 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical